Capricor Therapeutics Shareholder Alert: Deadline Looms for Class Action Lawsuit
Investors who suffered losses exceeding $100,000 in a class action lawsuit against Capricor Therapeutics must file lead plaintiff applications by September 28, 2026.
Shareholder information service ClaimsFiler is reminding investors of a deadline in a securities class action lawsuit filed against Capricor Therapeutics, Inc.
Investors who experienced losses of more than $100,000 must file applications to be lead plaintiff by September 28, 2026. The lawsuit alleges violations of securities laws by Capricor and some of its officers.
The suit claims that Capricor made misleading statements regarding its heart failure treatment, tesamorelin. Specifically, it is alleged that the company failed to disclose all material information regarding risks of cardiac arrest observed in clinical trials.
This legal development could impact the company's stock value and investor confidence as it progresses in its therapeutic development.